These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 36478297)

  • 21. The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients?
    Kurbel S
    Bioessays; 2021 Mar; 43(3):e2000112. PubMed ID: 33336824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19.
    Sparks MA; South A; Welling P; Luther JM; Cohen J; Byrd JB; Burrell LM; Batlle D; Tomlinson L; Bhalla V; Rheault MN; Soler MJ; Swaminathan S; Hiremath S
    Clin J Am Soc Nephrol; 2020 May; 15(5):714-716. PubMed ID: 32220930
    [No Abstract]   [Full Text] [Related]  

  • 23. Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis.
    Kerneis M; Ferrante A; Guedeney P; Vicaut E; Montalescot G
    Arch Cardiovasc Dis; 2020 Dec; 113(12):797-810. PubMed ID: 33199208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
    Steckelings UM; Sumners C
    Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of Angiotensin-(1-7) in COVID-19 Treatment.
    Luna P; Fernanda Pérez M; Castellar-Lopez J; Chang A; Montoya Y; Bustamante J; Rosales-Rada W; Mendoza-Torres E
    Curr Protein Pept Sci; 2023; 24(1):89-97. PubMed ID: 36453502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.
    Quarleri J; Delpino MV
    Geroscience; 2022 Apr; 44(2):547-565. PubMed ID: 35157210
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Ting R; Dutton H; Sorisky A
    Adipocyte; 2023 Dec; 12(1):2194034. PubMed ID: 36973648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
    Brojakowska A; Narula J; Shimony R; Bander J
    J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients.
    Silva-Aguiar RP; Peruchetti DB; Rocco PRM; Schmaier AH; E Silva PMR; Martins MA; Carvalho VF; Pinheiro AAS; Caruso-Neves C
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L596-L602. PubMed ID: 32783619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
    Simko F; Baka T
    Clin Sci (Lond); 2021 Apr; 135(8):1009-1014. PubMed ID: 33881142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
    Ahmadi S; Khaledi S
    Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections.
    Speth RC
    Drug Dev Res; 2020 Sep; 81(6):643-646. PubMed ID: 32304146
    [No Abstract]   [Full Text] [Related]  

  • 34. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection.
    Sinha A; Vaggu RG; Swain R; Patnaik S
    Curr Microbiol; 2023 Apr; 80(6):194. PubMed ID: 37106165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-Converting Enzyme 2 Roles in the Pathogenesis of COVID-19.
    Kenarkoohi A; Maleki M; Safari T; Kaffashian MR; Saljoughi F; Sohrabipour S
    Curr Hypertens Rev; 2021; 17(3):207-216. PubMed ID: 32778033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-Angiotensin System Inhibitors and the COVID-19 Pandemic.
    Muchaili L; Mweene BC; Masenga SK
    Am J Hypertens; 2023 Jun; 36(7):360-362. PubMed ID: 37010128
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
    Gemmati D; Tisato V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
    Dworakowska D; Grossman AB
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pathophysiology of Long COVID throughout the Renin-Angiotensin System.
    Khazaal S; Harb J; Rima M; Annweiler C; Wu Y; Cao Z; Abi Khattar Z; Legros C; Kovacic H; Fajloun Z; Sabatier JM
    Molecules; 2022 May; 27(9):. PubMed ID: 35566253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.